Latest Investigation News

Strategic Elements Limited is raising up to $1 million via a Share Purchase Plan (SPP) at 3.5 cents per share, with attaching options exercisable at 4 cents, to fuel development in Energy Ink™ and Stealth Technologies.

Patrys has appointed CMAX and Alithia Life Sciences to lead its Phase 1A clinical trial operations for RLS-2202, advancing its injectable quetiapine program toward first-in-human testing in Q3 2026, pending ethics approval.

EBR Systems has locked in a three-year purchasing agreement with CHRISTUS Health, the ninth-largest US hospital network, to advance its WiSE CRT System's US rollout across 66 hospitals.

Australia’s Treasurer has mandated six foreign shareholders to divest nearly 18% of Northern Minerals shares by early July, citing national security under the Foreign Acquisitions and Takeovers Act. Northern Minerals supports the move as vital for aligning with Australia’s strategic interests and advancing its Browns Range rare earths project.

Estrella Resources has launched a cutting-edge UAV-based electromagnetic survey at its Ira Miri manganese project to explore deeper and lateral extensions of high-grade mineralisation, aiming to refine geological models and support mining licence applications.

TG Metals is accelerating development at its Lake Johnston Lithium Project amid improved lithium prices, with mining lease applications and resource drilling approvals underway for the Burmeister deposit.

Barton Gold has launched an expedited 4,000m drilling program at its Tolmer Silver prospect, aiming to extend one of Australia's highest-grade silver discoveries following preliminary tests yielding concentrates over 100,000 g/t silver.

Amplia Therapeutics has launched a Phase 2b trial testing a new daily dosing regimen of narmafotinib combined with chemotherapy in advanced pancreatic cancer, aiming to accelerate progress towards a pivotal Phase 3 study.

EBR Systems has landed a significant purchasing agreement with Advocate Health, the third-largest US non-profit health system, opening access for its WiSE wireless cardiac pacing technology across 69 hospitals in eight states.

Algorae Pharmaceuticals has scaled its AI-driven drug synergy platform from one to 18 anchor drugs, generating over 9 million predictions and identifying thousands of promising combinations for cancer and other diseases.

ALS Limited reported a 25.8% jump in underlying net profit after tax to AUD 381.2 million for FY26, driven by strong commodity testing demand and margin expansion. The company raised its dividend and advanced major hub lab projects while navigating a post-year-end cyber incident.

Viridis Mining has delivered strong infill drilling results at its Colossus Rare Earth Project, boosting resource confidence and underpinning an imminent resource and reserve upgrade ahead of a Final Investment Decision in Q3 2026.